seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - drogy obštrukčnej choroby dýchacích ciest, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
fullhale 25 mikrogramov/250 mikrogramov/dávka inhalačná suspenzia v tlakovom obale
cipla europe nv, belgicko - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
fullhale 25 mikrogramov/125 mikrogramov/dávka inhalačná suspenzia v tlakovom obale
cipla europe nv, belgicko - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
asthmex 50 mikrogramov/500 mikrogramov dávkovaný inhalačný prášok
glenmark pharmaceuticals s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
asthmex 50 mikrogramov/250 mikrogramov dávkovaný inhalačný prášok
glenmark pharmaceuticals s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
asthmex 50 mikrogramov/100 mikrogramov dávkovaný inhalačný prášok
glenmark pharmaceuticals s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
serkep 25 mikrogramov/250 mikrogramov
viatris limited, Írsko - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
serkep 25 mikrogramov/125 mikrogramov
viatris limited, Írsko - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
flixotide 50 inhaler n
glaxosmithkline (ireland) limited, Írsko - flutikazón - 14 - bronchodilatantia, antiasthmatica
flixotide 125 inhaler n
glaxosmithkline (ireland) limited, Írsko - flutikazón - 14 - bronchodilatantia, antiasthmatica